STOCK TITAN

Curaleaf Announces New York Retail Expansion with Two New Medical Dispensaries and Adult-Use Sales at Two Existing Stores

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) has announced a significant expansion of its retail operations in New York. The company is opening two new medical dispensaries in Rochester and Syracuse, and introducing co-located adult-use sales at its existing Plattsburgh and Forest Hills locations. This expansion will increase Curaleaf's total retail footprint in New York to six dispensaries, with three offering both medical and adult-use sales.

The new Curaleaf Rochester location opened on July 25, while Curaleaf Syracuse is set to open in the coming weeks, pending regulatory approval. Both new medical dispensaries will be staffed with full-time pharmacists and offer a wide range of cannabis products. The company is also hosting grand opening events to celebrate the new locations.

This expansion aligns with Curaleaf's commitment to providing access to licensed, tested cannabis products for both medical patients and adult-use consumers across New York state.

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ha annunciato una significativa espansione delle sue operazioni di vendita al dettaglio a New York. L'azienda sta aprendo due nuovi dispensari medici a Rochester e Syracuse, introducendo anche vendite per uso adulto nelle sue attuali sedi di Plattsburgh e Forest Hills. Questa espansione aumenterà l'impronta totale di Curaleaf nel retail a New York a sei dispensari, con tre di essi che offriranno sia vendite mediche che per uso adulto.

La nuova sede di Curaleaf Rochester è stata inaugurata il 25 luglio, mentre Curaleaf Syracuse è prevista per aprire nelle prossime settimane, in attesa dell'approvazione normativa. Entrambi i nuovi dispensari medici saranno dotati di farmacisti a tempo pieno e offriranno una vasta gamma di prodotti a base di cannabis. L'azienda organizzerà anche eventi di apertura per celebrare le nuove sedi.

Questa espansione è in linea con l'impegno di Curaleaf a fornire l'accesso a prodotti di cannabis testati e autorizzati per pazienti medici e consumatori per uso adulto in tutto lo stato di New York.

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ha anunciado una expansión significativa de sus operaciones minoristas en Nueva York. La compañía abrirá dos nuevos dispensarios médicos en Rochester y Syracuse, e introducirá ventas para uso adulto en sus ubicaciones existentes de Plattsburgh y Forest Hills. Esta expansión aumentará la huella retail total de Curaleaf en Nueva York a seis dispensarios, de los cuales tres ofrecerán tanto ventas médicas como para uso adulto.

La nueva ubicación de Curaleaf Rochester se inauguró el 25 de julio, mientras que Curaleaf Syracuse está programada para abrir en las próximas semanas, a la espera de aprobación regulatoria. Ambos nuevos dispensarios médicos contarán con farmacéuticos a tiempo completo y ofrecerán una amplia gama de productos de cannabis. La compañía también organizará eventos de gran apertura para celebrar las nuevas ubicaciones.

Esta expansión está en línea con el compromiso de Curaleaf de proporcionar acceso a productos de cannabis licenciados y probados para pacientes médicos y consumidores de uso adulto en todo el estado de Nueva York.

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF)는 뉴욕에서 소매 운영을 대규모로 확장한다고 발표했습니다. 회사는 로체스터와 시러큐스에 두 개의 새로운 의료용 약국을 열고, 기존의 플랫스버그 및 포레스트 힐즈 장소에서 성인 사용 판매를 도입할 예정입니다. 이 확대는 Curaleaf의 뉴욕 내 소매 발자국을 여섯 개의 약국으로 늘리며, 그 중 세 곳은 의료용 및 성인 사용 판매를 모두 제공합니다.

새로운 Curaleaf Rochester 장소는 7월 25일에 개장했으며, Curaleaf Syracuse는 규제 승인이 완료되는 대로 몇 주 내에 열릴 예정입니다. 두 새로운 의료 약국은 전일제 약사로 구성되어 있으며, 다양한 대마초 제품을 제공합니다. 회사는 새로운 장소들을 축하하기 위한 개막 행사도 진행할 예정입니다.

이번 확장은 뉴욕 주 내 의료 환자와 성인 소비자에게 면허가 있으며 시험을 통과한 대마초 제품에 대한 접근을 제공하겠다는 Curaleaf의 약속과 일치합니다.

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) a annoncé une expansion significative de ses opérations de vente au détail à New York. L'entreprise ouvre deux nouveaux dispensaires médicaux à Rochester et Syracuse, et introduit des ventes pour adultes dans ses établissements existants à Plattsburgh et Forest Hills. Cette expansion portera le nombre total de dispensaires de Curaleaf à New York à six, dont trois proposeront à la fois des ventes médicales et pour adultes.

Le nouveau site Curaleaf Rochester a ouvert le 25 juillet, tandis que Curaleaf Syracuse doit ouvrir dans les semaines à venir, sous réserve d'une approbation réglementaire. Ces deux nouveaux dispensaires médicaux seront dotés de pharmaciens à plein temps et proposeront une large gamme de produits à base de cannabis. L'entreprise organisera également des événements d'inauguration pour célébrer les nouveaux emplacements.

Cette expansion s'aligne sur l'engagement de Curaleaf à fournir un accès à des produits de cannabis testés et autorisés pour les patients médicaux et les consommateurs adultes dans l'État de New York.

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) hat eine bedeutende Erweiterung ihrer Einzelhandelsaktivitäten in New York angekündigt. Das Unternehmen eröffnet zwei neue medizinische Apotheken in Rochester und Syracuse und führt an den bestehenden Standorten in Plattsburgh und Forest Hills den Verkauf für Erwachsene ein. Diese Erweiterung wird die gesamte Einzelhandelspräsenz von Curaleaf in New York auf sechs Apotheken erhöhen, von denen drei sowohl medizinische als auch Verkäufe für Erwachsene anbieten.

Der neue Standort Curaleaf Rochester eröffnete am 25. Juli, während Curaleaf Syracuse in den kommenden Wochen nach Genehmigung durch die Regulierungsbehörden eröffnet werden soll. Beide neuen medizinischen Apotheken werden mit Vollzeitapothekern besetzt sein und eine breite Palette von Cannabisprodukten anbieten. Das Unternehmen veranstaltet auch große Eröffnungsfeiern zur Feier der neuen Standorte.

Diese Expansion steht im Einklang mit Curaleafs Engagement, Patienten und Erwachsenen im Bundesstaat New York Zugang zu lizenzierten und getesteten Cannabisprodukten zu bieten.

Positive
  • Expansion of retail footprint in New York from 4 to 6 dispensaries
  • Introduction of co-located adult-use sales at two existing medical dispensaries
  • Opening of two new medical dispensaries in Rochester and Syracuse
  • Increased market presence in a key founding state for the Curaleaf brand
Negative
  • None.

New Rochester and Syracuse locations will expand the Company's retail footprint to six dispensaries in New York and 148 nationwide

Existing Curaleaf Plattsburgh and Curaleaf Forest Hills stores will now offer co-located medical and adult-use sales

STAMFORD, Conn., July 25, 2024 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced it will open two new medical dispensaries, and will begin co-located adult-use sales at two existing medical dispensaries in New York. Curaleaf Rochester, located at 532 Chili Ave, Rochester, NY 14611, will open later today, July 25 and Curaleaf Syracuse, located at 4141 South Salina St, Syracuse, NY 13205, will open in the coming weeks, pending regulatory approval. On July 20, co-located adult-use sales began at the existing medical store, Curaleaf Plattsburgh, and Curaleaf Forest Hills will begin co-located adult-use sales on July 26. This expansion will increase the Company's retail footprint in the Empire State to six total, with three co-located adult-use and medical locations, and three medical-only locations.

In celebration of the new store openings, Curaleaf Rochester will host a grand opening event on Friday, July 26, featuring live local music, food trucks, and prizes. Curaleaf Syracuse will host its grand opening at a later date, pending regulatory approval. Each new medical dispensary is staffed with a team of three full-time pharmacists to assist patients in exploring the Company's expansive collection of brands and products, including Grassroots indoor-grown flower, Select's full line up of vape and edible products including the new Select Fruit STIQ All-In-One Vape, JAMS edibles, B NOBLE, and New York's best-selling all-in-one two gram vape, Select BRIQ. 

Adult-use consumers and medical patients can maximize their retail experience by enrolling in Curaleaf Rewards to earn special offers and discounts. During each visit, Curaleaf's team of knowledgeable staff members will be available to provide assistance, answer questions, and guide consumers through the wide world of adult-use cannabis.

"We thank the Office of Cannabis Management for approving us to expand our operations to ensure even more New York patients and customers have access to licensed, tested cannabis across the state," said Matt Darin, CEO of Curaleaf. "From Rochester to Forest Hills, our team members are eager to welcome the newest members of our cannabis community while continuing to provide medical patients with the high-quality service and products they deserve. This is an exciting step forward for our retail operations in New York, which we consider to be a key founding state for the Curaleaf brand."

Curaleaf remains steadfast in its commitment to uplifting the medical patients and adult-use consumers of New York through health, wellness, and community. At each adult-use location, Curaleaf will continue to prioritize medical patients with access to dedicated staff members, industry-leading product offerings, and other amenities designed to provide a premier retail experience. For more information on Curaleaf's locations, patient resources, delivery program, and products in New York, please visit https://curaleaf.com/dispensary/new-york.

About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction, and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Forward Looking Statements:
This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the Company's expansion in New York. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed on March 6, 2024, which is available under the Company's SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.

Contacts:

Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
IR@curaleaf.com

Media Contact:
Curaleaf Holdings, Inc.
Jordon Rahmil, VP Corporate Communications
media@curaleaf.com

Cision View original content:https://www.prnewswire.com/news-releases/curaleaf-announces-new-york-retail-expansion-with-two-new-medical-dispensaries-and-adult-use-sales-at-two-existing-stores-302206333.html

SOURCE Curaleaf Holdings, Inc.

FAQ

When did Curaleaf (CURLF) open its new Rochester dispensary?

Curaleaf opened its new Rochester dispensary on July 25, 2024.

How many dispensaries will Curaleaf (CURLF) have in New York after this expansion?

After this expansion, Curaleaf will have a total of six dispensaries in New York.

Which Curaleaf (CURLF) locations in New York will offer co-located adult-use and medical sales?

Curaleaf Plattsburgh, Curaleaf Forest Hills, and one other location will offer co-located adult-use and medical sales in New York.

What products will be available at Curaleaf's (CURLF) new medical dispensaries in New York?

The new medical dispensaries will offer products including Grassroots indoor-grown flower, Select vape and edible products, JAMS edibles, B NOBLE, and Select BRIQ vapes.

CURALEAF HLDGS INC

OTC:CURLF

CURLF Rankings

CURLF Latest News

CURLF Stock Data

1.26B
595.63M
29.87%
2.97%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
New York